Rohiverth Guarecuco, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serum Albumin, Bovine | 1 | 2017 | 323 | 0.550 |
Why?
|
| Leukemia | 2 | 2020 | 1522 | 0.500 |
Why?
|
| Microspheres | 2 | 2017 | 785 | 0.490 |
Why?
|
| Vaccination | 2 | 2017 | 3360 | 0.260 |
Why?
|
| Aspartate-Ammonia Ligase | 1 | 2020 | 18 | 0.180 |
Why?
|
| Asparagine | 1 | 2020 | 119 | 0.170 |
Why?
|
| Thiamine | 1 | 2020 | 160 | 0.170 |
Why?
|
| Squalene | 1 | 2019 | 35 | 0.160 |
Why?
|
| Asparaginase | 1 | 2020 | 240 | 0.160 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13629 | 0.150 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2019 | 167 | 0.140 |
Why?
|
| Injections | 2 | 2017 | 830 | 0.140 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2016 | 24 | 0.140 |
Why?
|
| Polymethacrylic Acids | 1 | 2016 | 32 | 0.140 |
Why?
|
| Acetone | 1 | 2016 | 44 | 0.140 |
Why?
|
| Zinc Oxide | 1 | 2016 | 26 | 0.130 |
Why?
|
| Nanocomposites | 1 | 2016 | 49 | 0.130 |
Why?
|
| Organic Chemicals | 1 | 2016 | 211 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 1036 | 0.120 |
Why?
|
| Polyglycolic Acid | 1 | 2016 | 403 | 0.120 |
Why?
|
| Metabolome | 1 | 2019 | 976 | 0.110 |
Why?
|
| Lactic Acid | 1 | 2016 | 1132 | 0.090 |
Why?
|
| Antigens | 1 | 2015 | 1447 | 0.080 |
Why?
|
| Cholesterol | 1 | 2019 | 2925 | 0.080 |
Why?
|
| Kinetics | 1 | 2017 | 6378 | 0.080 |
Why?
|
| Antibodies | 1 | 2017 | 2424 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2978 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2019 | 2869 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6226 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3107 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1899 | 0.070 |
Why?
|
| Vaccines | 1 | 2015 | 833 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 1837 | 0.060 |
Why?
|
| Mice | 3 | 2020 | 81216 | 0.060 |
Why?
|
| Apoptosis | 1 | 2019 | 9497 | 0.050 |
Why?
|
| Diet | 1 | 2020 | 8008 | 0.050 |
Why?
|
| Animals | 6 | 2020 | 167940 | 0.050 |
Why?
|
| Delayed-Action Preparations | 2 | 2016 | 961 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10434 | 0.040 |
Why?
|
| Farnesyl-Diphosphate Farnesyltransferase | 1 | 2019 | 5 | 0.040 |
Why?
|
| Squalene Monooxygenase | 1 | 2019 | 11 | 0.040 |
Why?
|
| Temperature | 2 | 2016 | 2221 | 0.040 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2019 | 132 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 2019 | 251 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2019 | 491 | 0.030 |
Why?
|
| Drug Stability | 1 | 2016 | 290 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2020 | 2627 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 16905 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 1849 | 0.030 |
Why?
|
| Zinc | 1 | 2016 | 690 | 0.020 |
Why?
|
| Iron | 1 | 2019 | 1786 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4900 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3826 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7593 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 3145 | 0.020 |
Why?
|
| Female | 3 | 2019 | 391011 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 4546 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 2218 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 11902 | 0.010 |
Why?
|
| Humans | 4 | 2020 | 760261 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 58673 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 168995 | 0.000 |
Why?
|
| Male | 1 | 2019 | 359413 | 0.000 |
Why?
|